Rapt Therapeutics Inc
(RAPT)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Operating Expenses | 29,330 | 32,518 | 33,217 | 33,919 | 28,364 |
| Operating Income | -29,330 | -32,518 | -33,217 | -33,919 | -28,364 |
| Other Income | 1,667 | 1,997 | 2,341 | 2,548 | 3,084 |
| Pre-tax Income | -27,663 | -30,521 | -30,876 | -31,371 | -25,280 |
| Net Income Continuous | -27,663 | -30,521 | -30,876 | -31,371 | -25,280 |
| Net Income | $-27,663 | $-30,521 | $-30,876 | $-31,371 | $-25,280 |
| EPS Basic Total Ops | -5.69 | -6.32 | -6.48 | -6.56 | -5.28 |
| EPS Basic Continuous Ops | -5.69 | -6.32 | -6.44 | -6.54 | -5.28 |
| EPS Diluted Total Ops | -5.69 | -6.32 | -6.48 | -6.56 | -5.28 |
| EPS Diluted Continuous Ops | -5.69 | -6.32 | -6.44 | -6.54 | -5.28 |
| EPS Diluted Before Non-Recurring Items | -5.68 | -6.32 | -6.40 | N/A | N/A |
| EBITDA(a) | $-29,773 | $-33,187 | $-34,118 | $-35,158 | $-29,602 |